Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepato Cellular Carcinoma”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165
Not applicableStudy completedNCT07207304
What this trial is testing

Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic Processes

Who this might be right for
Hepato-cellular CarcinomaNeutrophil Extracellular Trap FormationAnesthesia+1 more
Iuliu Hatieganu University of Medicine and Pharmacy 153
Not applicableLooking for participantsNCT06960954
What this trial is testing

PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)Portal Vein Tumour Thrombosis
Tanta University 116
Testing effectiveness (Phase 2)Looking for participantsNCT07328009
What this trial is testing

A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 350
Not applicableNot Yet RecruitingNCT07704216
What this trial is testing

Peritumoral MRE Stiffness for Predicting Resection Margin Status and Recurrence in Liver Cancer

Who this might be right for
Hepato Cellular CarcinomaIntrahepatic Bile Duct CarcinomaMetastatic Hepatocellular Carcinoma
Second Affiliated Hospital of Xi'an Jiaotong University 150
Not applicableStudy completedNCT06720675
What this trial is testing

Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence

Who this might be right for
Liver CarcinomaLiver TransplantTumor Recurrence+2 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 237
Not applicableLooking for participantsNCT06723275
What this trial is testing

LEOPARD Prospective Validation Cohort 1

Who this might be right for
Decompensated Liver CirrhosisPrimary Biliary CholangitisPrimary Sclerosing Cholangitis+1 more
Assistance Publique - Hôpitaux de Paris 630
Not applicableUnknownNCT01322477
What this trial is testing

Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency

Who this might be right for
Hepatocellular Carcinoma
Hadassah Medical Organization 25
Large-scale testing (Phase 3)Looking for participantsNCT07302919
What this trial is testing

Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)
University Hospital, Basel, Switzerland 152
Testing effectiveness (Phase 2)Looking for participantsNCT07536789
What this trial is testing

Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 40
Not applicableNot Yet RecruitingNCT06894524
What this trial is testing

Retrospective Clinical Validation of HepatoPredict

Who this might be right for
Hepato Cellular Carcinoma (HCC)Liver ResectionLiver Transplantation
Ophiomics 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07487662
What this trial is testing

TACE or Ablation Combined With Sintilimab and Ipilimumab N01 as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With Intermediate-High Recurrence Risk

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Sun Yat-sen University 105
Testing effectiveness (Phase 2)Looking for participantsNCT07489976
What this trial is testing

IIT2025-03-YANG-LIFT-HCC

Who this might be right for
Hepato Cellular Carcinoma
Ju Dong Yang 41
Testing effectiveness (Phase 2)Looking for participantsNCT06742424
What this trial is testing

PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC

Who this might be right for
Hepato Cellular Carcinoma (HCC)
West China Hospital 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT07461675
What this trial is testing

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

Who this might be right for
Hepato Cellular Carcinoma (HCC)Immunotherapy
University of Geneva, Switzerland 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07494435
What this trial is testing

Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC

Who this might be right for
Hepato Cellular Carcinoma (HCC)Renal Cell Cancer
Zhejiang Haichang Biotech Co., Ltd. 230
Post-approval studies (Phase 4)Study completedNCT03706157
What this trial is testing

Kinectics of Distribution of Doxorubicin-Lipiodol Emulsion in c-TACE

Who this might be right for
Hepato Cellular Carcinoma
University Hospital, Strasbourg, France 10
Large-scale testing (Phase 3)Study completedNCT00858871
What this trial is testing

First Line Hepato Cellular Carcinoma (HCC)

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Bristol-Myers Squibb 1,714
Not applicableLooking for participantsNCT06675604
What this trial is testing

LEOPARD Training and Validation Data Collection Study

Who this might be right for
Decompensated Liver CirrhosisPrimary Biliary CholangitisPrimary Sclerosing Cholangitis+1 more
Assistance Publique - Hôpitaux de Paris 4,500
Not applicableLooking for participantsNCT07148310
What this trial is testing

Hepatocellular Carcinoma Identification Using Delta-HLD

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Epiliquid Holding, Inc 200
Next Page